Completed NCT02037074
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen for schizophrenia.
In Long Beach Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 60 Years
Countries United States
Sponsor FORUM Pharmaceuticals Inc
Condition Schizophrenia Completed NCT00690274
This summary needs review. Please check the official study record and contact the research team for details.
In Dallas Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor University of Texas Southwestern Medical Center
Condition Schizophrenia Completed NCT00076115
This study is completed. It is testing risperidone for Bipolarity.
Location not clearly listed Bipolarity Drug From 10 Years to 17 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Bipolarity Completed NCT02177903
This study is completed in Canada. It focuses on Anxiety.
In Vancouver Anxiety Device i A study involving a tool, app, wearable, test, or medical device. From 19 Years to 85 Years
Countries Canada
Sponsor Solventum US LLC
Condition Anxiety Completed NCT00187928
This study is completed in the United States. It is testing topiramate for OCD.
In Gainesville OCD Drug From 18 Years to 65 Years
Countries United States
Sponsor University of Florida
Condition OCD Completed NCT03150771
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04461119
This study is completed in the United States and in India. It focuses on schizophrenia.
Multiple locations, including Glendale Schizophrenia Drug Over 18 Years
Countries United States, India
Sponsor Newron Pharmaceuticals SPA
Condition Schizophrenia Completed NCT00399698
This study is completed in the United States. It focuses on ADHD.
In Columbus ADHD, Bipolarity Drug From 4 Years to 14 Years
Countries United States
Sponsor Ohio State University
Condition ADHD, Bipolarity Completed NCT02667210
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Addiction Other Over 18 Years
Countries
Sponsor Member Companies of the Opioid PMR Consortium
Condition Addiction Completed NCT04101227
This study is completed in Bulgaria, in Croatia, in Estonia, .... It is testing AD04 for Addiction.
Multiple locations, including Burgas Addiction Behavioral Over 18 Years
Countries Bulgaria, Croatia, Estonia, ...
Sponsor Adial Pharmaceuticals
Condition Addiction Completed NCT02824666
This study is completed in the United States. It focuses on Schizophrenia.
In Indianapolis Schizophrenia Behavioral From 18 Years to 50 Years
Countries United States
Sponsor Braeburn Pharmaceuticals
Condition Schizophrenia Completed NCT03397134
This study is completed in the United States, in Bulgaria, in Poland, .... It is testing roluperidone for schizophrenia.
Multiple locations, including Rogers Schizophrenia Drug From 18 Years to 55 Years
Countries United States, Bulgaria, Poland, ...
Sponsor Minerva Neurosciences
Condition Schizophrenia 
